We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Adverse Cardiac Events Are Rare After Negative Cardiac CTA Test

By HospiMedica International staff writers
Posted on 20 Oct 2010
Adverse cardiac events are uncommon one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to new research.

Cardiac CTA is a noninvasive heart-imaging imaging modality that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle. More...
Earlier discharge of patients with low-to-moderate risk chest pain after negative initial testing and a cardiac CTA scan without significant coronary artery disease (CAD) may result in considerable savings in both cost and time in the emergency department, and may help alleviate emergency department congestion. With increasing awareness of such cost and time savings, emergency department practice is gradually leading toward the use of early cardiac CTA in some centers.

The study, performed at the University of Washington School of Medicine (Seattle, WA, USA), included 70 patients with negative cardiac CTA results who were interviewed in detail at 3, 6, and 12 months about intervening cardiac events, diagnostic testing and therapy.

"No patient reported any sign, symptom, finding, or subsequent diagnosis suggestive of an adverse cardiac event, nor was there any such suggestion in the electronic medical record,” said William P. Shuman, M.D., lead author of the study. "For earlier discharge based, in part, on negative cardiac CTA results to be clinically efficacious, it must be a safe practice with few subsequent adverse cardiac events. Our study shows that for patients with low-to-moderate risk chest pain evaluated in the emergency department, adverse cardiac events may be rare during the year after a negative cardiac CTA scan,” he concluded.

This study appears in the October 2010 issue of the American Journal of Roentgenology (AJR).

Related Links:

University of Washington School of Medicine



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.